Amylin Pharmaceuticals said there have been four deaths among patients with pancreatitis who took its diabetes drug, Byetta. This is in addition to the reports of two other deaths.
The company said the four cases had not been reported last week to the FDA. The FDA had received six reports of patients who developed hemorrhagic or necrotizing pancreatitis that required hospitalization. Two of those patients died.
For more, go here.
